Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Academic & Non-Profit ResearchUniversities and Colleges without Dedicated Psychedelic Research Groups
Research, Drug Development & Manufacturing

The University of Melbourne

1 Trial1 Paper

The University of Melbourne is a leading public research university in Australia, with medical and psychological sciences programmes contributing to psychedelic and mental health research.

Academic Research

1 papers

Published Papers

1

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Mar 17, 2026

Quick Facts

Website
Visit

Sponsored Trials

1
Not yet recruitingIII

The Kite Trial: Examining the Effectiveness of Ketamine for Adults with Bipolar Depression

Start Date
Compounds
Ketamine, Placebo

Research Papers

1
Open Accessindividual

Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response

This retrospective study (n=101) of inpatients with treatment-resistant depression (TRD) found that intranasal esketamine led to significant reductions in depression severity, with 28.8% achieving response and 19.3% remission. Older age was associated with greater remission likelihood, and extended induction beyond eight sessions appeared particularly beneficial for older patients and those with psychiatric comorbidities, with no serious adverse events observed.

Published
Journal
BMC Psychiatry
Authors
Baune, B. T., Rosemann, K., Hefter, D., Tonkul, M., Kavakbasi, E.